|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.09.26 - 14:06
|
McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date (Business Wire)
|
|
|
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
The live and archived audio webcast will be available on McKesson's Investor Relations website.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.
We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09.09.26 - 14:09
|
Frazier Healthcare Partners Welcomes Tom Rodgers as Senior Partner (Business Wire)
|
|
|
SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Tom Rodgers will join the firm as a Senior Partner in October 2026. In this role, Mr. Rodgers will partner with Frazier's Growth Buyout deal teams, providing strategic counsel on investment evaluation, portfolio value creation, and sector-level insights informed by more than 35 years of experience in healthcare strategy, corporate development, and venture investing.
Mr. Rodgers most recently served as Chief Strategy Officer of McKesson Corporation, where he was a member of the company's Executive Operating Team during a period of significant growth and strategic transformation. In that capacity, he oversaw McKesson's enterprise growth strategy, acquisition pipeline, venture investments, and an internal innovation team. Prior to his role as CSO, he led the launch and successful scaling of McKesson's venture fund and earlier in his career directed strat...
|
|
|
08.09.26 - 15:03
|
Reliant Infusion Names Tommy Pourmahram Chief Executive Officer (Business Wire)
|
|
|
Former McKesson Oncology & Multispecialty executive joins the Shore Capital-backed specialty infusion provider to accelerate its regional and national expansionCHICAGO--(BUSINESS WIRE)--Shore Capital Partners ("Shore" or "Shore Capital"), a Chicago-based private equity firm with an office in Nashville, today announced that Tommy Pourmahram has been named Chief Executive Officer of Reliant Infusion, a Shore portfolio company and provider of specialty infusion services.
Pourmahram brings more than 20 years of healthcare leadership to the role, most recently in senior executive positions at McKesson's Oncology & Multispecialty Segment. McKesson is a recognized leader in community oncology and specialty care and one of the largest diversified healthcare services companies in the United States. Pourmahram held commercial and operating leadership roles that contributed directly to the segment's growth and its position as a leader in the specialty market.
His experience spans specialty health, drug infusion, o...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
